Work

A Dose and Schedule Finding Study of Maintenance Therapy with Low-Dose 5-Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High-Risk AML or MDS.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.3012.3012

Authors: Marcos de Lima, L. Padua, S. Giralt, C. Hosing, K. Komanduri, M. Qazilbash, E.J. Shpall, P. Thall, S. Qureshi, G. McCormick, W. Tong, U. Popat, A. Soriano, R. Champlin, G. Garcia-Manero

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2560777339

FWCI: 1.481

Cites:

Cited by: 8

Related to: 10